Akèy › Miasteni grav › Michigan › Detroit
Etid klinik pou Miasteni grav nan Detroit, MI
6 etid pou Miasteni grav ap chèche patisipan nan sit nan ak bò kote Detroit (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia Gravis
Ap rekriteFaz 3
- Henry Ford Hospital, Detroit
ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis
Ap rekriteEtid obsèvasyon
- Henry Ford Health System, Detroit
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod
Ap rekriteFaz 2
- Henry Ford Health Systems, Detroit
Study to Assess the Efficacy and Safety of IMVT-1402 in Participants With Mild to Severe Generalized Myasthenia Gravis
Ap rekriteFaz 3
- Site Number - 1026, Detroit
A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases
Ap rekriteFaz 1
- Karmanos Cancer Institute, Detroit
A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
Ap rekriteEtid obsèvasyon
- Henry Ford Health System, Detroit
Etid Miasteni grav nan lòt vil
- Tampa, FL12 etid
- Houston, TX11 etid
- Durham, NC10 etid
- Boca Raton, FL10 etid
- Columbus, OH8 etid
- Miami, FL7 etid
- New York City, NY7 etid
- Milwaukee, WI7 etid
- St. Louis, MO7 etid
- Boston, MA6 etid
- Washington, DC6 etid
- San Francisco, CA6 etid
Lòt etid nan Detroit
- Kansè Poumon ki pa ti selil44 etid
- Kansè nan tete33 etid
- Kansè (tout kalite)29 etid
- Kansè kolorektal26 etid
- Kansè ovè26 etid
- Kansè Metastatik24 etid
- Kansè pwostat22 etid
- Kansè Endomèt21 etid
- Kansè poumon20 etid
- Myelom Miltip19 etid
- Kansè lestomak16 etid
- Karsinòm selil skuamèz tèt ak kou15 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.